CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Ironwood
Pharmaceuticals, Inc. (NASDAQ: IRWD) will present at the Jefferies
2011 Global Healthcare Conference on Monday, June 6, 2011 at 11:30 a.m.
Eastern Time at the Grand Hyatt in New York City. Ironwood will also
present at the Goldman Sachs 32nd Annual Global Healthcare
Conference on Wednesday, June 8, 2011 at 8:00 a.m. Pacific Time / 11:00
a.m. Eastern Time at the Terranea Resort in Rancho Palos Verdes, Calif.
A live webcast of each Ironwood presentation will be accessible through
the Investors section of the company's website at www.ironwoodpharma.com.
To access the webcast, please log on to the Ironwood website
approximately 15 minutes prior to the start of the presentation to
ensure adequate time for any software downloads that may be required. A
replay of each webcast will be available on Ironwood's website for 14
days following each conference.
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (NASDAQ: IRWD) is an entrepreneurial
pharmaceutical company dedicated to the art and science of great
drugmaking. Linaclotide, Ironwood's GC-C agonist, is in Phase 3 clinical
development for the treatment of irritable bowel syndrome with
constipation (IBS-C) and chronic constipation. The efficacy portion of
linaclotide's development program has been completed and will support
the NDA submission for both indications, as well as the MAA submission
for the IBS-C indication. Ironwood also has a growing pipeline of
additional drug candidates in earlier stages of development. Ironwood is
located in Cambridge, Mass. To learn more, visit www.ironwoodpharma.com.
Ironwood Pharmaceuticals
Susan Brady, 617-621-8304
sbrady@ironwoodpharma.com
Source: Ironwood Pharmaceuticals, Inc.
News Provided by Acquire Media